Samsung Medical Center

Seoul, Seoul 06351

5 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Brain Tumor, Chronic Myelomonocytic Leukemia, Idiopathic Pulmonary Fibrosis, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Large B-cell Lymphoma, Leukemia, Myeloid, Acute, Light Chain (AL) Amyloidosis, Myelodysplastic Syndrome With Excess Blasts-2, Non Small Cell Lung Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Refractory AML

Studies at this site

• A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer — Recruiting now
• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL — Recruiting now
• Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets — Recruiting now
• UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies — Recruiting now
• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia — Recruiting now
• Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF — Running, not enrolling
• A Study of NB003 in Patients With Advanced Malignancies — Completed
• A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis — Stopped early